Kewaunee Scientific (KEQU) vs Personalis (PSNL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Personalis (PSNL) has outperformed Kewaunee Scientific (KEQU) over the past year, gaining 111.4% versus a loss of 22.9%. Over five years, KEQU leads with a +156.4% price change compared with -19.8% for PSNL. Personalis is the larger company by market cap ($1.72 billion vs $97.9 million), about 17.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KEQU | PSNL |
|---|---|---|
| Share price | $33.82 | $16.06 |
| Market cap | $97.92M | $1.72B |
| 1-day change | -0.06% | +0.37% |
| YTD return | -9.54% | +101.01% |
| 1-year return | -22.92% | +111.36% |
| 5-year return | +156.36% | -19.76% |
| P/E ratio (TTM) | 12.25 | — |
| Forward P/E | 15.66 | — |
| EPS (TTM) | $2.76 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.57 | $18.89 |
| 52-week low | $32.00 | $4.96 |
| Distance from 52-week high | -27.38% | -14.98% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | -5.54% |
| Average volume | 4.21K | 3.59M |
| Shares outstanding | 2.90M | 106.80M |
| Employees | — | 259 |
| Sector | Industrials | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Personalis is about 17.5 times larger than Kewaunee Scientific by market value ($1.72B vs $97.92M).
- PSNL has outperformed KEQU by 134.3 percentage points over the past year.
- The two companies sit in different sectors: Kewaunee Scientific in Industrials and Personalis in Health Care.
About Personalis
PSNL stock →Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Health Care · Medical Specialities · 259 employees
KEQU vs PSNL FAQ
Which is bigger, Kewaunee Scientific or Personalis?
Personalis (PSNL) is larger, with a market capitalization of $1.72B compared with $97.92M for Kewaunee Scientific (KEQU).
Which stock has performed better over the past year, KEQU or PSNL?
PSNL returned +111.36% over the past 12 months, compared with -22.92% for KEQU (price return, excluding dividends). Past performance does not predict future results.
Are Kewaunee Scientific and Personalis in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Industrials sector.